Cannabis use widespread in France

In 2021, half of the adult population in France declared having consumed cannabis in their lifetime, highlighting the drug's prevalence and the need for further research on its health impacts.

Long history of cannabis cultivation

Humans have been cultivating cannabis for 12,000 years and have used it for its psychoactive effects for at least 2,500 years, demonstrating its long-standing role in human culture and medicine.

Perceived benefits of cannabis

Popular beliefs suggest cannabis could offer a harmless and natural alternative to pharmaceutical products for treating pain, nausea, muscle spasms, lack of appetite, and post-traumatic stress disorder, leading to increased interest in its medical potential.

FDA approval and health risks

Studies show cannabis can help relieve cancer-related pain, and the Food and Drug Administration has approved two synthetic cannabinoid-based medications to reduce nausea and vomiting in cancer patients. However, research also indicates potential long-term risks for the lungs, heart, intestines, and mental health.

Contested effectiveness for pain relief

The effectiveness of cannabis as a pain reliever remains contested. While pain management is a primary reason for medical cannabis use in the United States, studies report mixed results regarding pain relief in the general population.

Lack of endorsement by medical associations

The International Association for the Study of Pain has not endorsed cannabis-based medications due to a lack of demonstrated effectiveness in recognized studies. A systematic review found that the placebo effect may account for some of the reported analgesic benefits.

Cannabis not as dangerous as opioids

Experts caution that cannabis is not as dangerous as opioids but can have other consequences on physical and psychological health, including increased potency of cannabis strains, hallucinations or paranoia from daily consumption, and the existence of cannabis addiction.

Cannabinoid hyperemesis syndrome

Cannabinoid hyperemesis syndrome (CHS), first described in 2004, has become a significant issue, with estimates suggesting 2.75 million people in the United States are affected annually. The syndrome involves recurrent episodes of nausea, vomiting, and abdominal pain, and stopping cannabis use is the only long-term solution.

Health risks related to heart conditions

THC in cannabis affects blood circulation, increasing the risk of heart attack and stroke by 25 and 42 percent, respectively, in regular users. This risk is higher in cannabis smokers due to inhaled particles alongside THC.

Indica and sativa distinctions questioned

The distinction between cannabis strains indica and sativa, often associated with different effects, is largely considered insignificant by researchers. Scientific evidence shows no significant chemical or genetic differences between the two varieties, and the lack of legislative framework for strain taxonomy has led to inconsistencies in labeling.